- ￥1168 - 1868
- abinScience
- France
- HF638025
- 2026年09月03日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
香烟烟雾如何加速声带纤维化？CD44-透明质酸轴是关键通路Takara 秋促来袭，提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ￥1200阿拉丁 22万+ 科研级产品现货速发，品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃
- 保质期：
12 months
- 英文名：
Anti-Human a1AT/Serpin A1/SERPINA1 Monoclonal Antibody (1A546)
- 供应商：
武汉研升生物科技有限公司
- 规格：
50μg/100μg
| 规格： | 50μg | 产品价格： | ￥1168.0 |
|---|---|---|---|
| 规格： | 100μg | 产品价格： | ￥1868.0 |
| 产品名称 | Anti-Human a1AT/Serpin A1/SERPINA1 Monoclonal Antibody (1A546) |
| 货号 | HF638025 |
| 描述 | Anti-Human a1AT/Serpin A1/SERPINA1 Monoclonal Antibody (1A546) [1A546] ( HF638025 ) is a mouse monoclonal antibody detecting Alpha-1-antitrypsin in ELISA, IHC, WB . Suitable for Human . Highlights Recombinant — Superior batch-to-batch reproducibility with defined sequences. Multi-Application — Validated across multiple applications. |
| 反应种属 | Human |
| 应用实验 | ELISA, IHC, WB |
| 宿主/表达体系 | Mouse |
| 克隆类型 | Monoclonal |
| 靶点 | Alpha-1-antitrypsin, Alpha-1 protease inhibitor, Alpha-1-antiproteinase, Serpin A1, Short peptide from AAT, SPAAT, SERPINA1 |
| 基因号 | P01009 |
| 状态 | Liquid |
| 储存温度 | -20℃ |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Human Monoclonal Antibodies: The Residual Challenge of Antibody Immunogenicity
One of the major reasons for seeking human monoclonal antibodies has been to eliminate immunogenicity seen with rodent antibodies. Thus far, there has yet been no approach which absolutely abolishes that risk for cell-binding antibodies
Generation of a Monoclonal Antibody Library Against Human Embryonic Stem Cells
Differentiated cell types derived from human embryonic stem cells (hESCs) may serve in the future to treat various human diseases and to model early human embryonic development in vitro. Fulfilling this potential, however, requires extensive
Monoclonal Antibody-Based Strategies in Autoimmunity and Transplantation
of therapeutic monoclonal antibodies in the fields of transplantation and autoimmunity, and discuss the salient features of antibodies presently used in the clinic-notably anti-T-cell and anticytokine antibodies. The discussion will also focus on the unique
技术资料暂无技术资料 索取技术资料
